These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 13040333)
41. [Prevention of recurrence of thromboembolic disease: maintenance of anticoagulant therapy]. Enrico JF Ther Umsch; 1989 Oct; 46(10):732-8. PubMed ID: 2814910 [TBL] [Abstract][Full Text] [Related]
42. Oral anticoagulant prophylaxis against venous thrombolism. Morris GK Scott Med J; 1978 Oct; 23(4):325-7. PubMed ID: 725590 [No Abstract] [Full Text] [Related]
43. [Bleedings during vitamin K antagonist therapy associated with ciclosporin and rifampicin]. Chouchana L; Languille E; Weiss N; Billaud EM; Lillo-Le Louet A Presse Med; 2013 May; 42(5):908-11. PubMed ID: 23069229 [No Abstract] [Full Text] [Related]
44. Single-center determination of reference factor II and factor X activity level values for the monitoring of vitamin K antagonist therapy. Désage S; Jousselme E; Négrier C; Nougier C; Le Quellec S; Jourdy Y Int J Lab Hematol; 2019 Oct; 41(5):e121-e123. PubMed ID: 31012536 [No Abstract] [Full Text] [Related]
45. [Physiologic and physiopathologic bases of a rational anticoagulant therapy]. Raby C Maroc Med; 1970 Mar; 50(533):129-45. PubMed ID: 5517522 [No Abstract] [Full Text] [Related]
46. Clinical experiences with 4-hydroxycoumarin anticoagulant No. 63 and the antagonistic effect of menadione and vitamin K. HANSON HH; BARKER NW; MANN FD Circulation; 1951 Dec; 4(6):844-63. PubMed ID: 14879492 [No Abstract] [Full Text] [Related]
47. Effects of the anticoagulant diphenadione on suckling calves. Elias DJ; Thompson RD; Savarie PJ Bull Environ Contam Toxicol; 1978 Jul; 20(1):71-8. PubMed ID: 581268 [No Abstract] [Full Text] [Related]
48. Improved control of long-term anticoagulant therapy. Eastham RD Br Med J; 1968 May; 2(5601):337-40. PubMed ID: 5648973 [No Abstract] [Full Text] [Related]
51. [Experimental-clinical study of a new anticoagulant phenylindandione]. BLEKSMIT ZD; KOTOVSHCHIKOVA MA; MARTYNOVA NV Vestn Khir Im I I Grek; 1958 Aug; 81(8):64-8. PubMed ID: 13593117 [No Abstract] [Full Text] [Related]
52. [Prevention of thromboembolic complications with adapted low-dose of antivitamins K after total hip prosthesis]. Hernigou P; Février MJ; Kergrohen F Rev Chir Orthop Reparatrice Appar Mot; 1993; 79(7):577-85. PubMed ID: 8085039 [TBL] [Abstract][Full Text] [Related]
53. The effectiveness of an oral vitamin K1 in controlling excessive hypoprothrombinemia during anticoagulant therapy. COSGRIFF SW Ann Intern Med; 1956 Jul; 45(1):14-22. PubMed ID: 13340565 [No Abstract] [Full Text] [Related]
54. Control of anticoagulant therapy. A comparison of the thrombotest, the prothrombin-proconvertin method, and the prothrombin time. FICHERA C Acta Med Scand; 1962 Sep; 172():363-7. PubMed ID: 13945019 [No Abstract] [Full Text] [Related]
55. A critical evaluation of anticoagulant therapy. Wright IS Geriatrics; 1969 Mar; 24(3):96-100. PubMed ID: 4885555 [No Abstract] [Full Text] [Related]
57. [Anticoagulant prophylaxis: from clinical trials to clinical practice]. Scardi S; Mazzone C G Ital Cardiol; 1998 Feb; 28(2):178-86. PubMed ID: 9534059 [TBL] [Abstract][Full Text] [Related]
58. [Research on anticoagulant effect of phenylindanedione and its relation to the substances with vitamin P effect]. LONGO G Haematologica; 1954; 38(9):1161-8. PubMed ID: 13221125 [No Abstract] [Full Text] [Related]
59. [Treatment of thrombosis with 2-phenylinandion]. HAASE HW; BUSCHER G Zentralbl Chir; 1955; 80(31):1260-7. PubMed ID: 13274989 [No Abstract] [Full Text] [Related]
60. Dipaxin: 2-diphenylacetyl-1,3-indandione; clinical evaluation of a new anticoagulant. FIELD JB; GOLDFARB MS; WARE AG; GRIFFITH GC Circulation; 1955 Apr; 11(4):576-83. PubMed ID: 14364732 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]